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ABSTRACT  
Background: Circadian disruption caused by exposure to light at night (LAN) has been 
proposed as a risk factor for breast cancer and a reason for secular increases in incidence. 
Studies to date have largely been ecological or case-control in design and findings have 
been mixed. 
Methods: We investigated the relationship between LAN and breast cancer risk in the UK 
Generations Study. Bedroom light levels and sleeping patterns at age 20 and at study 
recruitment were obtained by questionnaire. Analyses were conducted on 105,866 
participants with no prior history of breast cancer. During an average of 6.1 years of follow-
up, 1,775 cases of breast cancer were diagnosed. Cox proportional hazard models were 
used to calculate hazard ratios (HRs), adjusting for potential confounding factors. 
Results: There was no association between LAN level and breast cancer risk overall 
(highest compared with lowest LAN level at recruitment: HR=1.01 (95% Confidence interval 
(CI): 0.88-1.15), or for invasive  (HR=0.98 (95% CI: 0.85-1.13) or in situ  HR=0.96 (95% CI: 
0.83-1.11) breast cancer, or oestrogen-receptor (ER) positive (HR=0.98, 95% CI: 0.84-1.14); 
or negative (HR=1.16, 95% CI: 0.82-1.65) tumours separately. The findings did not differ by 
menopausal status. Adjusting for sleep duration, sleeping at unusual times (non-peak sleep) 
and history of night work did not affect the results. Night waking with exposure to light, 
occurring around age 20, was associated with a reduced risk of premenopausal breast 
cancer (HR for breast cancer overall=0.74, 95% CI: 0.55-0.99; HR for ER-positive breast 
cancer=0.69, 95% CI: 0.49-0.97). 
Conclusion: In this prospective cohort analysis of LAN, there was no evidence that LAN 
exposure increased the risk of subsequent breast cancer, although the suggestion of a lower 
breast cancer risk in pre-menopausal women with a history of night waking in their twenties 
may warrant further investigation.  
Key words: breast cancer, cohort study, light at night, risk 
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INTRODUCTION 
 
Breast cancer is the most common cancer diagnosed in women worldwide and incidence 
continues to rise. Internationally, the highest rates are seen in economically developed 
countries (DeSantis et al., 2015). This pattern of incidence, coupled with observations from 
migration studies (Ziegler et al., 1993;Deapen et al., 2002), is consistent with a strong role 
for lifestyle and environmental factors influencing breast cancer risk. 
In 1978 Cohen et al (Cohen et al., 1978) suggested that disruption to circadian rhythm could 
result in higher circulating estrogen levels and thereby increase the risk of breast cancer, 
and in 1987 Stevens (Stevens, 1987) proposed that secular trends in breast cancer 
incidence might be explained by increasing exposure to artificial light. The hypothesised 
mechanism is via melatonin, a hormone secreted by the pineal gland in response to 
decreases in ambient light (Huether, 1993;Brainard et al., 2001).  
This ‘light at night’ (LAN) theory has stimulated epidemiological investigations. To date, most 
studies have been either ecological in design, correlating cancer incidence rates in 
populations with estimates of outdoor ambient LAN (Kloog et al., 2008;Kloog et al., 2010;Kim 
et al., 2016), or case-control studies, examining risks associated with self-reported measures 
of indoor LAN (Davis et al., 2001;O'Leary et al., 2006;Bauer et al., 2013). These have 
disadvantages in that the former do not analyse on an individual basis and the latter have 
potential for recall and selection biases. Only one cohort study has been published, which 
found an increased risk in relation to outdoor LAN, measured by satellite, but not indoor 
LAN, measured by questionnaire (Hurley et al., 2014). Overall, epidemiological findings have 
been inconsistent, and the metrics analysed have varied and not been clearly comparable 
(O'Leary et al., 2006;Bauer et al., 2013;Hurley et al., 2014).  
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Here we report a cohort study of the relationship between LAN and subsequent breast 
cancer risk, based on data from women recruited to the UK Generations Study.  
METHODS 
 
Study population 
This analysis is based on the Generations Study (GS), a cohort study of >113,000 women 
from the UK, recruited at ages ≥16 years since 2003. Recruitment involved a baseline postal 
questionnaire about established and potential breast cancer risk factors, and donation of a 
blood sample. Participants are followed up approximately every three years, by postal or 
online questionnaires, to obtain updated risk factor and outcome information (further detail in 
Swerdlow et al (Swerdlow et al., 2011)). The study was undertaken with informed consent 
and ethics approval from the South East Multi-Centre Research Ethics Committee.  
 
Cancers occurring in the cohort were identified from recruitment and follow-up 
questionnaires, spontaneous reports to the study centre, and  ‘flagging’ at the National 
Health Service Central Registers, virtually complete registers of the population of the 
country, which notify cancer registrations, deaths and emigrations in study subjects to 
authorised medical researchers. Confirmation of self-reported cancer diagnoses were 
obtained from medical records.   
 
Exposure assessment  
Information on LAN and sleep patterns in GS participants was obtained at recruitment. 
Women were asked to report their level of exposure to LAN over the year prior to recruitment 
and at age 20 years, in the room in which they slept, in the categories; ‘light enough to read’; 
‘light enough to see across the room, but not read’; ‘light enough to see your hand in front of 
you, but not to see across the room’; and ‘too dark to see your hand, or you wear a mask’.  
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Covariate information 
Detailed information on established breast cancer risk factors was collected by the GS at 
recruitment and was updated, where applicable, at follow-up rounds (Swerdlow et al., 2011). 
Information on history of night shift work (defined as work between 22:00 and 07:00) 
obtained at baseline was used to derive a dichotomous variable for ever/never night work 
during the 10 years before recruitment. The average number of times GS participants woke 
during the night and put on a light or entered a bright room over the year prior to recruitment 
and at age 20 years was collected at baseline. Non-peak sleep (Davis et al., 2001) was 
assessed as going to sleep at or after 2:00am or rising for the day at or before 1:00am. GS 
participants were also asked about average sleep duration, which was  used to derive a 
dichotomous variable  <7 hours vs,  ≥7 hours sleep per night, based on median sleep in the 
GS cohort and thresholds used in other studies (Verkasalo et al., 2005;Pinheiro et al., 
2006;Kakizaki et al., 2008). 
 
Statistical analysis  
The current analytic cohort is based on all women who were recruited to the study during 
June 2003 to June 2012 inclusive, and who had not previously been diagnosed with breast 
cancer. Follow-up for breast cancer started at the date of receipt of the recruitment 
questionnaire and ended on the earliest of: breast cancer, death, date of mailing for follow-
up questionnaires, or if the follow-up questionnaire was not returned and the woman was 
covered by ‘flagging’, the earliest of the date the individual’s ‘flagging’ coverage ended (i.e. 
when she was removed  from the NHS Central Register), or the date after which ‘flagging’ 
notification was not yet complete (taken to be 1 March 2014). If the follow-up questionnaire 
was not returned and the woman was not covered by ‘flagging’ (<1.2 % of the cohort), the 
follow-up was truncated at the date of her last returned questionnaire. 
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Only a small proportion of women reported LAN in the lightest category (‘light enough to 
read’; 0.96% for the year before recruitment and 1.92% at age 20). This group was therefore 
combined with the adjacent group (‘light enough to see across the room, but not read’). Cox 
proportional hazards regression (Cox, 1972) using attained age as the implicit timescale was 
used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer 
risk in relation to LAN exposure. To control for potential confounding by other breast cancer 
risk factors, we adjusted for year of birth, history of benign breast disease, history of breast 
cancer in a first-degree relative, socioeconomic score, age at menarche, age at first birth, 
parity, duration of breastfeeding, oral contraceptive (OC) use before menopause, hormone 
replacement therapy (HRT) use, menopausal status, age at menopause, pre-menopausal 
and post-menopausal body mass index, alcohol consumption, smoking and leisure time 
physical activity (in metabolic equivalents, METS, hours/week), with time-varying data 
incorporated for age at first birth, parity, menopausal status, age at menopause, OC use and 
HRT use. Socioeconomic score was based on place of residence (Acorn scores (Solutions 
CI, 2002)). 
 
Results are presented by oestrogen-receptor (ER) status of breast cancer and menopausal 
status during follow-up. Age at menopause was assumed to be 50 years for women whose 
menopausal status or age at menopause was not known. Analyses presented in the Tables 
are for invasive plus in situ breast cancer combined, but we also conducted analyses 
separately for invasive and in situ disease and for broad morphological groups (ductal, 
lobular, other/not known), which are reported in the text. Analyses were also adjusted for 
ever night shift work, sleep duration, and non-peak sleep to investigate their potential impact. 
 
All statistical tests were performed using Stata/IC version 14.0 (StataCorp, 2015) and all 
reported P-values were two-sided . 
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RESULTS 
 
Of the 113,207 women recruited to the GS during June 2003 - June 2012, 6,581 were 
excluded from analysis because of prior breast cancer, 14 due to prior bilateral mastectomy 
and 746 due to missing LAN information, leaving 105,866 women included in the analysis. 
Their mean age at recruitment was 46.5 years (range 16 to 102 years) and mean follow-up 
was 6.1 years (standard deviation=1.0). Follow-up by questionnaire (96.3%) or ‘flagging’ 
(1.7%) was complete for 98% of women, 0.8% (n=809) had died and 1.2% (n=1,323) were 
lost to follow-up (e.g. by emigration). During follow-up, 1,775 breast cancers (1,503 invasive 
and 272 in situ) were diagnosed. ER status was ascertained for 99% of invasive and 58% of 
in situ cases; the latter was lower because hormone receptor assays are often not 
undertaken for in situ lesions in the UK. Histology was ascertained for 95% of cases. Further 
details of breast cancer cases are described in Supplementary Table 1. 
Characteristics of the cohort are shown in Table 1. Women from earlier birth cohorts tended 
to report lower LAN levels, but overall, ‘medium’ levels of LAN were the most common, 
reported by 49% of participants for the year before recruitment and 47% of participants for 
age 20. Overall, 97% (n=102,972) of participants in this analysis reported LAN information at 
age 20. A greater proportion of women reported waking at night and turning on lights or 
going into a bright room during the year before recruitment than at age 20 (37% vs 10%, 
respectively, P<0.001). Seventeen percent of participants reported a history of night shift 
work during the 10 years before recruitment (we did not have consistent information on shift 
work before that).  
There was no statistically significant association between breast cancer risk and LAN level in 
the year before recruitment or at age 20, when adjusted for age and year of birth. The HR for 
the highest LAN compared with the lowest LAN category at recruitment was 1.01 (95% CI: 
0.88-1.15; Table 2) and for LAN at age 20 was 1.00 (95% CI: 0.88-1.15; Table 3). For pre-
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menopausal breast cancer, the adjusted HR for the highest vs lowest LAN level at 
recruitment was 1.00 (95% CI: 0.81-1.24) and at age 20 was 0.91 (95% CI: 0.73-1.13). 
Similarly, there was no significant association between LAN and breast cancer risk when the 
analysis was limited to post-menopausal follow-up (Table 2). Analyses in relation to 
oestrogen receptor sub-type showed no association: for LAN at recruitment, the HR for ER-
positive breast cancer was 0.98 (95% CI: 0.84-1.14) and for ER-negative disease was 1.16 
(95% CI: 0.82-1.65).  
 
When analyses were repeated to investigate the risk of invasive and in situ breast cancer 
separately, results were very similar to those for breast cancer overall: HR=0.98 (95% CI: 
0.85-1.13) for invasive and HR=0.96 (95% CI: 0.83-1.11) for in situ breast cancer for the 
highest vs lowest LAN level at recruitment (not in Table). Similarly, there was no association 
between LAN and the risk of different morphological subtypes of breast cancer: for the 
highest vs lowest level LAN at recruitment, ductal HR=1.00 (95% CI: 0.86-1.16), lobular 
HR=0.92 (95% CI: 0.66-1.28) and other types HR=1.41 (95% CI: 0.85-2.35) (not in Table).  
There was no relationship between reported night waking with exposure to light in the year 
before recruitment and risk of breast cancer (HR=1.01, 95% CI: 0.92-1.12; Table 4). 
Similarly, there was no association between this exposure and breast cancer risk in pre- or 
post-menopausal women and results did not differ by ER status of breast cancer. For night 
waking with light exposure at age 20, however, there was a reduced risk of pre-menopausal 
breast cancer (HR=0.74, 95% CI: 0.55-0.99, P=0.04; Table 5), with a reduced risk of ER-
positive (HR=0.69, 95% CI: 0.49-0.97, P=0.03), but not ER-negative (HR=0.91, 95% CI: 
0.45-1.82) cancers and no effect for post-menopausal breast cancer. 
There was no impact on our results when analyses comparing the highest LAN vs lowest 
LAN categories at recruitment were adjusted for history of night shift work in the ten years 
before recruitment (HR=1.01, 95% CI: 0.88-1.15), duration of sleep (HR=1.01, 95% CI: 0.89-
1.15) or non-peak sleep (HR=1.01, 95% CI: 0.88-1.15) (not in Table). 
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DISCUSSION 
 
 
It has been hypothesised that suppression of nocturnal pineal melatonin production in 
response to light at night might explain the rises in breast cancer rates that have 
accompanied industrialisation and electrification in westernised countries (Stevens, 1987). 
Exposure to artificial light during the night can disrupt the circadian rhythm and reduce the 
normal nocturnal rise in melatonin (Stevens, 1987; Stevens and Rea, 2001; Claustrat et al., 
2005; Stevens et al., 2007; Straif et al., 2007), leading to an increase in circulating oestrogen 
levels (Cohen et al., 1978;Cos and Sanchez-Barcelo, 2000) and suppression of tumour anti-
proliferative processes, which might increase breast cancer risk (Stevens, 1987;Stevens and 
Rea, 2001;Hill et al., 2015). 
Clearly, if circadian disruption of melatonin plays a substantial role in in the aetiology of 
breast cancer, it is of major public health importance. Following early epidemiologic studies 
(Davis et al., 2001;Hansen, 2001;Schernhammer et al., 2001;O'Leary et al., 2006), the 
World Health Organisation has designated night shift work involving LAN-induced 
circadian/melatonin disruption as a probable carcinogen (class 2a) and risk factor for the 
development of breast cancer (Straif et al., 2007). In Denmark this led to a change to 
occupational compensation law (Wise, 2009). 
In our analysis of over 105,000 UK women, we found no evidence of a relationship between 
self-reported level of domestic exposure to light at night and subsequent raised risk of breast 
cancer. Published ecological studies using satellite data to derive LAN exposure in Israel, 
South Korea and worldwide have tended to show high light levels associated with a 30-70% 
increased risk of breast cancer (Kloog et al., 2008;Kloog et al., 2010;Kim et al., 2016). 
Findings from case-control studies conducted in a number of countries, have been more 
mixed.  Using self-reported bedroom LAN data, several studies found statistically non-
significant increased risks ranging from 10-50% (Davis et al., 2001;O'Leary et al., 2006;Li et 
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al., 2010;Keshet-Sitton et al., 2016). Statistically significant increased risks  of 10-20% have, 
however, been reported by case-control studies of LAN exposure in Israel  (Kloog et al., 
2011) and the US (Bauer et al., 2013). Ecological and case-control study designs have 
disadvantages, however: potential confounding by other factors affecting breast cancer risk, 
inability to link exposure directly to individual outcome in ecological studies, and potential 
selection and recall biases in case-control studies. Cohort studies provide a mechanism for 
avoiding these deficiencies. To the best of our knowledge, the only previously published 
cohort study was that by Hurley et al (Hurley et al., 2014) among teachers in California. That 
analysis of 106,731 female Californian teachers found an increased risk of breast cancer for 
women living in areas with the highest quintile of estimated outdoor LAN exposure as 
assessed from satellite data, but no effect of indoor LAN assessed from questionnaire 
responses incorporating duration of use. 
When we examined LAN effects in pre- and post-menopausal women separately, we found 
no difference in breast cancer risk in relation to bedroom light level by menopausal status. A 
small number of published studies investigated risk by menopausal status. In the only cohort 
study (Hurley et al., 2014), there was a more pronounced risk of breast cancer associated 
with outdoor LAN in pre-menopausal than post-menopausal women, while in case-control 
studies, Li et al (Li et al., 2010) observed a non-significant increased risk in post-menopausal 
women only and O’Leary et al  (O'Leary et al., 2006) found similar LAN effects irrespective 
of menopausal status. 
In addition to light at night, a range of other exposure variables have been used to assess  
potential disruption to circadian rhythm, such as duration of sleep, non-peak sleep, night 
waking with exposure to light, and night shift work (Davis et al., 2001; Schernhammer et al., 
2001; Straif et al., 2007; Keshet-Sitton et al., 2016; Qian et al., 2015; Li et al., 2010; O'Leary 
et al., 2006). There is a potential interplay between these variables and LAN. For example, 
people who have difficulty sleeping may spend more time awake with a light on during the 
night. Similarly, non-peak sleep may result in increased exposure to artificial light during the 
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hours of natural darkness. In our study, there was still no association between LAN exposure 
and risk of breast cancer after adjustment for average sleep duration and nonpeak sleep. 
Likewise, after adjustment for history of night shift work in the ten years before recruitment, 
we found no association between bedroom LAN and risk of breast cancer. Studies have 
shown that intermittent nocturnal light exposure of sufficient intensity lowers melatonin levels 
(Bojkowski et al., 1987; Brzezinski, 1997;Travlos et al., 2001). In our study, we found self-
reported night waking with light exposure at age 20 was associated with a decreased risk of 
pre-menopausal breast cancer, particularly ER-positive cancer. Epidemiological 
investigations of night waking that leads to light exposure have had mixed findings: one 
study (Davis et al., 2001) found no relation, whilst another (O'Leary et al., 2006) found a 
significant 65% increase in breast cancer risk. 
Major strengths of our study are its prospective design, large study population size, 
comprehensive assessment of breast cancer risk factors and very high follow-up rates. The 
detailed information on established breast cancer risk factors available within the GS allowed 
us to adjust for a wide range of potentially confounding factors in our analyses. The 
Californian Teachers cohort study and most case-control studies have adjusted for the major 
recognised breast cancer risk factors, but few ecological studies, with the exception of Kloog 
et al (Kloog et al., 2008) have been adjusted for potential confounders. Our study also has 
the advantage of having information on reported LAN at age 20.  
LAN reflects the degree of exposure to internal lights left on at night, plus both the extent of 
external light (natural and artificial) and the extent of window covering blocking light entry. 
The LAN measure we used takes in all of these factors, whereas a residential address only 
gives potential information on external light. Thus a woman in a dark rural area with no street 
lighting might nevertheless leave her bedroom light on at night and sleep with high LAN, and 
a woman in a city centre might use shutters or blinds to keep out external light and hence 
sleep in total darkness. A potential limitation of our study is that it uses self-reported LAN 
exposure information. However, since this information was ascertained before breast cancer 
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occurrence, it should not have biased the results. Misclassification would be likely to have 
diluted any true relation, but the lack of any sign of raised risk does not suggest a 
relationship.  
In conclusion, we found no evidence of an association between LAN exposure and raised 
risk of breast cancer in this large UK-based cohort study. Although our findings raise the 
possibility of a protective effect in pre-menopausal women who reported night waking with 
exposure to light at age 20, this was a subset analysis with modest statistical significance, 
based on relatively few breast cancer cases, has not been reported elsewhere, and has no 
plausible mechanism, so cannot be taken as strong evidence unless confirmed 
independently.  
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Table 1 Characteristics of Generations Study participants included in the 
analysisa 
Characteristic   No. (%) 
Year of birth             1908-1949 29,228 (27.6) 
                                 1950-1959 25,516 (24.1) 
                                 1960-1969 24,054 (22.7) 
 1970-1996 27,068 (25.6) 
Age at recruitment (years) <20 1,178 (1.1) 
 
20-39 33,482 (31.6) 
 
40-49 24,340 (23.0) 
 
50-59 26,922 (25.4) 
 
≥60 19,944 (18.8) 
Ethnicity White 104,595 (98.8) 
 
Other or not stated 1,271 (1.2) 
Socioeconomic status at recruitmentb 1 (highest) 46,168 (43.6) 
 
2 10,224 (9.7) 
 
3 31,732 (30.0) 
 
4 11,749 (11.1) 
 
5 (lowest) 4,778 (4.5) 
 
Not classifiable 1,215 (1.2) 
Menopausal status at recruitment                                 Post-menopausal 41,181 (38.9) 
 
Pre-menopausal 59,499 (56.2) 
                                 Never had periods 34 (0.0) 
 
Not known 5,152 (4.9) 
Light at nightc 
  
 
       At recruitment Low 22,155 (20.9) 
 
Med 51,889 (49.0) 
High 31,822 (30.1) 
       At age 20 years Low 18,750 (17.7) 
 
Med 50,116 (47.3) 
 
High 34,106 (32.0) 
Not applicabled 1,178 (1.1) 
History of night shift work during 
preceding 10 years Not known 1,716 
 
(1.6) 
 No 87,935 (83.1) 
 
Yes 17,931 (16.9) 
Waking at night and exposed to lighte    
      At recruitment No 58,818 (55.6) 
                                  Yes 38,710 (36.6) 
 
Not known 8,338 (7.9) 
     At age 20 years No 82,936 (78.3) 
 
Yes 10,183 (9.6) 
Not applicabled 1,178 (1.1) 
Non-peak sleepf Not known 11,569 (10.9) 
 
No 105,116 (99.3) 
 Yes 750 (0.7) 
Sleep duration per night (hours) <7 19,288 (18.2) 
 
≥7 85,807 (81.1) 
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Not known 771 (0.7) 
Total participants  105,866 (100.0) 
 
Abbreviations: SD Standard deviation 
a  At recruitment unless otherwise stated 
b  Based on place of residence ACORN score (Solutions CI, 2002)  
c  Low: ‘Too dark to see your hand, or you wear a mask’; Med: ‘Light enough to see your hand in front of you, but not 
see across the room’; High: ‘Light enough to see across the room, but not read’ + ‘Light enough to read’ 
d  Aged < 20 at recruitment 
e  Wake and put the lights on or go into a bright room 
f Going to sleep at or after 2:00am or rising for the day at or before 1:00am (Davis et al., 2001). 
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Table 2 Light at night at recruitment and risk of breast cancer, by menopausal status and oestrogen-receptor status of breast cancer 
      Oestrogen-receptor status of breast cancer 
  All breast cancers  Positive  Negative 
 
LAN 
levela 
No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
             
Total (Pyrs=640,832) 
Low 416 1.00   330 1.00   54 1.00  
Med 847 1.00 (0.89-1.12) 0.97  661 0.99 (0.87-1.13) 0.88  134 1.20 (0.88-1.65) 0.26 
 
High 512 1.01 (0.88-1.15) 0.92  391 0.98 (0.84-1.14) 0.78  77 1.16 (0.82-1.65) 0.40 
     
 
   
 
   
Pre-menopausal breast cancer 
(Pyrs=373,323) 
Low 145 1.00   115 1.00   19 1.00  
Med 326 0.91 (0.74-1.10) 0.33  250 0.89 (0.71-1.11) 0.30  53 1.09 (0.64-1.84) 0.75 
 
High 219 1.00 (0.81-1.24) 1.00  165 0.97 (0.76-1.24) 0.82  31 1.04 (0.59-1.85) 0.89 
     
        
Post-menopausal breast cancer 
(Pyrs=267,509) 
Low 271 1.00   215 1.00   35 1.00  
Med 521 1.05 (0.91-1.22) 0.48  411 1.05 (0.89-1.24) 0.55  81 1.26 (0.84-1.87) 0.26 
 
High 293 1.00 (0.85-1.18) 1.00  226 0.97 (0.81-1.17) 0.77  46 1.23 (0.79-1.92) 0.36 
 
Abbreviations: LAN Light At Night; HR Hazard Ratio; CI Confidence Interval; Pyrs person-years of follow-up 
a Low: ‘Too dark to see your hand, or you wear a mask’; Med: ‘Light enough to see your hand in front of you, but not see across the room’;  
High: ‘Light enough to see across the room, but not read’ + ‘Light enough to read’ 
b  Hazard ratios estimated using Cox proportional hazards regression with attained age as time scale, adjusted for: year of birth, history of benign breast disease, breast 
cancer in a first-degree relative, socioeconomic score, age at menarche, age at first birth, parity, duration of breastfeeding, oral contraceptive use, hormone 
replacement therapy use, menopausal status and age at menopause where applicable, pre-menopausal and post-menopausal body mass index, alcohol 
consumption, smoking and physical activity level. 
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Table 3 Light at night (LAN) at age 20 and risk of breast cancer, by menopausal status and oestrogen-receptor status of breast cancer 
      Oestrogen-receptor status of breast cancer 
  All breast cancers  Positive  Negative 
 
LAN 
levela 
No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
             
Total (Pyrs=624,049) 
Low 452 1.00   269 1.00   57 1.00  
Med 846 1.02 (0.90-1.16) 0.76  674 1.07 (0.93-1.24) 0.34  118 0.86 (0.63-1.18) 0.36 
 
High 540 1.00 (0.88-1.15) 0.97  409 1.00 (0.86-1.17) 0.96  84 0.94 (0.67-1.32) 0.73 
     
 
   
 
   
Pre-menopausal breast cancer 
(Pyrs=364,008) 
Low 125 1.00   93 1.00   22 1.00  
Med 321 0.88 (0.71-1.08) 0.21  247 0.92 (0.72-1.16) 0.48  49 0.73 (0.44-1.21) 0.22 
 
High 238 0.91 (0.73-1.13) 0.40  185 0.97 (0.76-1.25) 0.81  31 0.64 (0.37-1.11) 0.11 
     
 
   
 
   
Post-menopausal breast cancer 
(Pyrs=260,042) 
Low 227 1.00   176 1.00   35 1.00  
Med 525 1.11 (0.95-1.29) 0.20  427 1.17 (0.98-1.39) 0.09  69 0.93 (0.62-1.39) 0.72 
 
High 302 1.04 (0.88-1.24) 0.63  224 1.00 (0.821.22) 0.99  53 1.17 (0.76-1.80) 0.47 
 
Abbreviations: LAN Light At Night; HR Hazard Ratio; CI Confidence Interval; Pyrs person-years of follow-up 
a Low: ‘Too dark to see your hand, or you wear a mask’; Med: ‘Light enough to see your hand in front of you, but not see across the room’;  
High: ‘Light enough to see across the room, but not read’ + ‘Light enough to read’ 
b  Hazard ratios estimated using Cox proportional hazards regression with attained age as time scale, adjusted for: year of birth, history of benign breast disease, breast 
cancer in a first-degree relative, socioeconomic score, age at menarche, age at first birth, parity, duration of breastfeeding, oral contraceptive use, hormone 
replacement therapy use, menopausal status and age at menopause where applicable, pre-menopausal and post-menopausal body mass index, alcohol 
consumption, smoking and physical activity level. 
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Table 4 Night waking with exposure to lighta in the year before recruitment and risk of breast cancer, by menopausal status and 
oestrogen receptor status of breast cancer 
      Oestrogen-receptor status of breast cancer 
  All breast cancers  Positive  Negative 
 
Night 
waking 
No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
  
 
 
 
 
 
 
 
 
 
 
 
Total (Pyrs=640,832) 
No 939 1.00   729 1.00   142 1.00  
Yes 674 1.01 (0.92-1.12) 0.82  524 1.01 (0.90-1.13) 0.90  100 1.01 (0.78-1.32) 0.91 
 
N/k 162 1.00 (0.84-1.18) 0.99  129 1.01 (0.83-1.22) 0.93  23 1.00 (0.64-1.56) 0.99 
     
 
   
 
   
Pre-menopausal breast cancer 
(Pyrs=373,323) 
No 412 1.00   317 1.00   59 1.00  
Yes 247 1.10 (0.93-1.29) 0.26  188 1.09 (0.91-1.31) 0.35  39 1.24 (0.82-1.86) 0.31 
 
N/k 31 0.63 (0.43-0.91) 0.01  25 0.64 (0.43-0.97) 0.04  5 0.81 (0.32-2.03) 0.65 
     
 
   
 
   
Post-menopausal breast cancer 
(Pyrs=267,509) 
No 527 1.00   412 1.00   83 1.00  
Yes 427 0.96 (0.85-1.10) 0.58  336 0.96 (0.83-1.11) 0.62  61 0.90 (0.64-1.26) 0.54 
 N/k 131 1.15 (0.95-1.40) 0.16 
 104 1.16 (0.93-1.45) 0.18  18 1.03 (0.62-1.74) 0.90 
 
Abbreviations: HR Hazard Ratio; CI Confidence Interval; Pyrs person-years of follow-up 
a  Wake and put the lights on or go into a bright room 
b  Hazard ratios estimated using Cox proportional hazards regression with attained age as time scale, adjusted for: light at night in the year before recruitment, year of 
birth, history of benign breast disease, breast cancer in a first-degree relative, socioeconomic score, age at menarche, age at first birth, parity, duration of 
breastfeeding, oral contraceptive use, hormone replacement therapy use, menopausal status and age at menopause where applicable, pre-menopausal and post-
menopausal body mass index, alcohol consumption, smoking and physical activity level. 
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Table 5 Night waking with exposure to lighta at age 20 and risk of breast cancer, by menopausal status and oestrogen receptor status of 
breast cancer 
      Oestrogen-receptor status of breast cancer 
  All breast cancers  Positive  Negative 
 
Night 
waking 
No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
 No. 
cases HR (95% CI)b P-value 
             
Total (Pyrs=640,832) 
No 1450 1.00   1130 1.00   220 1.00  
Yes 103 0.85 (0.70-1.04) 0.12  77 0.82 (0.65-1.04) 0.10  15 0.82 (0.49-1.40) 0.47 
 
N/k 222 0.91 (0.78-1.05) 0.20  175 0.90 (0.77-1.07) 0.23  30 0.85 (0.57-1.26) 0.41 
     
 
   
 
   
Pre-menopausal breast cancer 
(Pyrs=373,323) 
No 593 1.00   457 1.00   88 1.00  
Yes 50 0.74 (0.55-0.99) 0.04  36 0.69 (0.49-0.97) 0.03  9 0.91 (0.45-1.82) 0.79 
 
N/k 47 0.65 (0.48-0.87) 0.01  37 0.65 (0.46-0.91) 0.01  6 0.64 (0.28-1.49) 0.30 
     
 
   
 
   
Post-menopausal breast cancer 
(Pyrs=267,509) 
No 857 1.00   673 1.00   132 1.00  
Yes 53 0.96 (0.73-1.27) 0.80  41 0.95 (0.69-1.30) 0.74  6 0.72 (0.32-1.63) 0.43 
 
N/k 175 1.02 (0.86-1.21) 0.80  138 1.02 (0.84-1.23) 0.85  24 0.93 (0.60-1.46) 0.76 
 
Abbreviations: HR Hazard Ratio; CI Confidence Interval; Pyrs person-years of follow-up 
a  Wake and put the lights on or go into a bright room 
b  Hazard ratios estimated using Cox proportional hazards regression with attained age as time scale, adjusted for: light at night at age 20, light at night in the year 
before recruitment, year of birth, history of benign breast disease, breast cancer in a first-degree relative, socioeconomic score, age at menarche, age at first birth, parity, 
duration of breastfeeding, oral contraceptive use, hormone replacement therapy use, menopausal status and age at menopause where applicable, pre-menopausal and post-
menopausal body mass index, alcohol consumption, smoking and physical activity level. 
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Supplementary Table 1 Characteristics of breast cancer cases included in the analysis 
Characteristic 
 Breast cancer cases 
 No. % 
Age at recruitment (years) <20 0 0% 
 20-39 164 9% 
 40-49 455 26% 
 50-59 600 34% 
 ≥60 556 31% 
    
Socioeconomic status at recruitment 1 (highest) 904 51% 
 2 141 8% 
 3 514 29% 
 4 153 9% 
 5 (lowest) 48 3% 
 Not classifiable 15 1% 
    
Menopausal status at recruitment                                 Post-menopausal 1028 58% 
 Pre-menopausal 650 37% 
                                  Never had periods 1 <1% 
 Not known 96 5% 
    
Menopausal status at breast cancer diagnosis Post-menopausal 1085 61% 
 Pre-menopausal 690 39% 
    
Age at breast cancer diagnosis 20-29 7 <1% 
 30-39 86 5% 
 40-49 341 19% 
 50-59 530 30% 
 60-69 631 36% 
 70-79 161 9% 
 ≥80 19 1% 
    
Confirmation of breast cancer Yesa 1773 >99% 
 Nob 2 <1% 
    
Invasive status Invasive 1503 85% 
 In situ 272 15% 
    
Histological type Ductal 1366 77% 
 Lobular 274 15% 
 Other 42 2% 
 Not Known 93 5% 
    
Oestrogen-receptor (ER) status Positive 1382 78% 
 Negative 265 15% 
 Not known 128 7% 
Confirmation of breast cancer cases: a Yes=Confirmation through national cancer registration or medical records; b No=with 
reported treatments that may imply self-reported diagnosis of breast cancer is correct 
